The research team used whole-genome sequencing to evaluate the relationships of isolates and also analyzed infection prevention measures such as hand hygiene adherence, access to alcohol-based hand rubs, and cleaning of high-touch surfaces.
An international team of researchers has analyzed human remains from 21 archaeological sites to learn more about the impact and evolution of the plague-causing bacterium Yersinia pestis during the first plague pandemic (541-750 AD).
Identifying vulnerabilities to outbreaks of Ebola and Lassa fever is possible following new research from the University of Surrey and University of Cambridge.
Scientists have used gene-editing techniques to stop the bird flu virus from spreading in chicken cells grown in the lab. The findings raise the possibility of producing gene-edited chickens that are resistant to the disease.
Chikungunya virus, once confined to the Eastern Hemisphere, has infected more than 1 million people in the Americas since 2013, when mosquitoes carrying the virus were discovered in the Caribbean. Most people who become infected develop fever and joint pain that last about a week.
Infection Control Today is bringing back a much-loved feature, Bug of the Month, which helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today.
In a new study published today in the Journal of Allergy and Clinical Immunology, scientists from King's College London have found that young children with severe eczema infected with Staphylococcus aureus (SA) bacterium, are at a higher risk of developing a food allergy.
In a new study, described in Nature, Rockefeller scientists showed that microbes under viral attack turn their defenses not only on their enemies, but also on themselves.
A potential therapeutic strategy to treat viral infection and boost immunity against cancer is reported in the May 30 online issue of the journal Cell.
The experimental antiviral drug remdesivir completely protected four African green monkeys from a lethal dose of Nipah virus, according to a new study in Science Translational Medicine from National Institutes of Health scientists and colleagues.
Manuka honey could provide the key to a breakthrough treatment for cystic fibrosis patients following preliminary work by experts at Swansea University.